Related Experiment Video
Updated: Jun 25, 2025

08:17
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
15.7K
Technical note: Patient-specific quality assurance for multi-target single-isocenter SRS-A target-specific approach
1Department of Radiation Oncology, Indiana University Health Arnett, Lafayette, Indiana, USA.
Medical Physics
|May 29, 2024
Summary
This study presents a new method for patient-specific quality assurance (PSQA) in multi-target single-isocenter (MTSI) stereotactic radiosurgery (SRS) planning. The approach ensures high precision and reliability in dose coverage for each target, achieving over 95.5% passing rates.
Area of Science:
- Medical Physics
- Radiation Oncology
- Radiosurgery
Background:
- Advancements in radiotherapy necessitate improved planning for multi-target intracranial stereotactic radiosurgery (SRS).
- Multi-target-single-isocenter (MTSI) planning enhances beam delivery precision and reduces treatment time.
- Current patient-specific quality assurance (PSQA) methods are often impractical for accommodating all targets in a single QA session.
Purpose of the Study:
- To develop and validate a novel PSQA approach for MTSI cases.
- To ensure precise dose coverage for individual targets or neighboring target groups (T-NTG) within MTSI plans.
- To adapt existing QA devices for comprehensive assessment of complex SRS plans.
Main Methods:
- Utilized a custom script to calculate T-NTG coordinates relative to the beam isocenter.
- Created individual QA verification plans for each T-NTG, repositioning the beam isocenter for precise alignment with the SRS MapCHECK (SRS MC).
- Performed gamma-index analysis (GIA) using CBCT images for SRS MC alignment and assessed passing rates (PR) for 75 QA plans using 6MV-FFF beams and Volumetric Modulated ARC Therapy (VMAT).
Main Results:
- Achieved a PR > 95.5% for all QA plans using the 1.0 mm/2.0% GIA criteria, with an average PR of 98.9%.
- 63% of plans achieved PR > 99.0%, and 92% achieved PR > 97.0%.
- Statistical analysis indicated that the PSQA method consistently approaches a 99% PR, demonstrating its reliability for targets, including those in the lateral dose-fall-off regions.
Conclusions:
- The proposed PSQA method, involving T-NTG relocation, is a reliable and clinically acceptable tool for MTSI SRS.
- This approach effectively addresses the limitations of single-session QA for complex multi-target SRS cases.
- The findings support the routine implementation of this PSQA strategy in radiation oncology departments.

